HALO
Halozyme Therapeutics Inc
Price:  
41.11 
USD
Volume:  
1,265,534.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

HALO Intrinsic Value

%
Upside

As of 2024-03-02, the Intrinsic Value of Halozyme Therapeutics Inc (HALO) is 48.03 USD. This HALO valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 41.11 USD, the upside of Halozyme Therapeutics Inc is %.

The range of the Intrinsic Value is 32.17 - 85.62 USD

41.11 USD
Stock Price
48.03 USD
Intrinsic Value
Intrinsic Value Details

HALO Intrinsic Value - Valuation Summary

Range Selected Upside
a
DCF (Growth 5y) 32.17 - 85.62 48.03 16.8%
DCF (Growth 10y) 51.64 - 125.69 73.75 79.4%
DCF (EBITDA 5y) 45.20 - 67.11 49.87 21.3%
DCF (EBITDA 10y) 61.85 - 94.23 70.42 71.3%
Fair Value 55.51 - 55.51 55.51 35.03%
P/E 53.24 - 65.57 61.96 50.7%
EV/EBITDA 41.62 - 60.95 43.86 6.7%
EPV 13.75 - 20.80 17.27 -58.0%
DDM - Stable 17.52 - 48.04 32.78 -20.3%
DDM - Multi 29.99 - 65.58 41.35 0.6%

HALO Intrinsic Value - Key Valuation Metrics

Market Cap (mil) 5,213.57
Beta 1.31
Outstanding shares (mil) 126.82
Enterprise Value (mil) 6,594.45
Market risk premium 4.60%
Cost of Equity 10.02%
Cost of Debt 4.31%
WACC 8.59%